Status:
COMPLETED
Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation
Lead Sponsor:
Derince Training and Research Hospital
Conditions:
Lidocaine
Eligibility:
All Genders
18-80 years
Brief Summary
Direct laryngoscopy and endotracheal intubation procedure stimulate the sympathetic nervous system, causing catecholamine release into the circulation and consequently hemodynamic changes.There are ma...
Detailed Description
2% lidocaine drug to suppress the hemodynamic response due to laryngoscopy and endotracheal intubation; patients administered intravenously will be evaluated in one group, and patients administered in...
Eligibility Criteria
Inclusion
- Patients over the age of 18 and under the age of 80 who underwent surgery under general anesthesia
Exclusion
- Patients under the age of 18 and over the age of 80
- Patients who are not operated under general anesthesia
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 22 2024
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT06107543
Start Date
December 1 2023
End Date
June 22 2024
Last Update
June 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Derince Training and Research Hospital
Kocaeli, Turkey (Türkiye), 41900